Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadroparin vs TIPS in Refractory Asymptomatic Portal Vein Thrombosis
NCT06319131Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- May 2024
- Primary completion
- May 2025
01
Overview
Randomised, open-label trial (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Complete Recanalization Rate of PVT at 6 months. Planned start May 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06319131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319131.